(Q41706099)

7 October 2017

1 reference

title

Clinical pharmacokinetics and pharmacodynamics of torasemide (English)

1 reference

7 October 2017

1 reference

H Knauf

1

1 reference

PubMed ID

9474471

7 October 2017

E Mutschler

series ordinal

2

1 reference

7 October 2017

1 January 1998

1 reference

Clinical Pharmacokinetics

7 October 2017

1 reference

7 October 2017

34

1 reference

7 October 2017

1

1 reference

7 October 2017

1-24

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199834010-00001

7 October 2017

0 references

cites work

Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion

1 reference

12 December 2020

The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency.

1 reference

12 December 2020

Comparison of loop diuretics in patients with chronic renal insufficiency

1 reference

12 December 2020

Diuretic resistance: mechanisms and therapeutic strategies.

1 reference

12 December 2020

Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

1 reference

12 December 2020

Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy

1 reference

12 December 2020

How Do Loop Diuretics Act?

1 reference

12 December 2020

Clinical pharmacology of loop diuretics

1 reference

12 December 2020

A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers

1 reference

12 December 2020

Efficacy and tolerance of low-dose loop diuretics in hypertension

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites

1 reference

12 December 2020

Sequential nephron blockade breaks resistance to diuretics in edematous states

1 reference

12 December 2020

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure

1 reference

12 December 2020

The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency

1 reference

12 December 2020

Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension

1 reference

12 December 2020

Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure

1 reference

12 December 2020

Bumetanide and furosemide in heart failure

1 reference

12 December 2020

Clinical pharmacology of torasemide, a new loop diuretic

1 reference

12 December 2020

Low dose loop diuretics in essential hypertension. Experience with torasemide

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease

1 reference

12 December 2020

Pharmacokinetics and metabolism of torasemide in man

1 reference

12 December 2020

Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure

1 reference

12 December 2020

Xipamide disposition in liver cirrhosis

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function

1 reference

12 December 2020

Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver

1 reference

12 December 2020

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

1 reference

12 December 2020

Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.

1 reference

12 December 2020

The determination of torasemide and metabolites in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Furosemide in patients with heart failure: shift in dose-response curves

1 reference

12 December 2020

The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.

1 reference

12 December 2020

Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update

1 reference

12 December 2020

Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy

1 reference

12 December 2020

[Pharmacokinetics of triamterene in healthy subjects and patients with liver and kidney function disorders]

1 reference

12 December 2020

Response to furosemide in chronic renal insufficiency: rationale for limited doses

1 reference

12 December 2020

Benefits and risks of torasemide in congestive heart failure and essential hypertension

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure

1 reference

12 December 2020

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis

1 reference

12 December 2020

Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).

1 reference

12 December 2020

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

1 reference

12 December 2020

The role of low-dose diuretics in essential hypertension

1 reference

12 December 2020

Functional state of the nephron and diuretic dose-response--rationale for low-dose combination therapy.

1 reference

12 December 2020

Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Disposition and diuretic effect of furosemide in the nephrotic syndrome.

1 reference

12 December 2020

The pharmacodynamics of torsemide in patients with congestive heart failure.

1 reference

12 December 2020

Acute and chronic effects of torasemide in healthy volunteers

1 reference

12 December 2020

Torasemide, a new potent diuretic. Double-blind comparison with furosemide

1 reference

12 December 2020

Solid-phase extraction and liquid chromatography of torsemide and metabolites from plasma and urine

1 reference

12 December 2020

Effect of Food on the Pharmacokinetics and Pharmacodynamics of Torsemide.

1 reference

12 December 2020

Body fluid homeostasis in congestive heart failure and cirrhosis with ascites

1 reference

12 December 2020

The time course of delivery of furosemide into urine: an independent determinant of overall response

1 reference

12 December 2020

Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers

1 reference

12 December 2020

Diuretics as antihypertensive drugs

1 reference

12 December 2020

10.2165/00003088-199834010-00001

Identifiers

DOI

1 reference

PubMed ID

9474471

Dimensions Publication ID

7 October 2017

0 references

1 reference

PubMed ID

9474471